ApoE ε4 positive multiple sclerosis patients develop more gray matter and whole brain atrophy: a 4-year longitudinal study using the 15-year disease onset model

被引:0
|
作者
Horakova, Dana [1 ]
Kyr, Michal [2 ,3 ]
Havrdova, Eva [1 ]
Dolezal, Ondrej [1 ]
Seidl, Zdenek [4 ]
Vaneckova, Manuela [4 ]
Pospisilova, Lenka [5 ]
Dwyer, Michael G. [6 ]
Stosic, Milena [6 ]
Cox, Jennifer L. [6 ]
Bergsland, Niels [6 ]
Zivadinov, Robert [6 ]
机构
[1] Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic
[2] Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic
[3] Masaryk Univ, Fac Med, Ctr Biostat & Analyses, Brno, Czech Republic
[4] Charles Univ Prague, Dept Radiol, Fac Med 1, Prague, Czech Republic
[5] Charles Univ Prague, Fac Med 1, Dept Pediat, Prague, Czech Republic
[6] SUNY Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA
来源
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S68 / S69
页数:2
相关论文
共 12 条
  • [1] Apolipoprotein E ε4-Positive Multiple Sclerosis Patients Develop More Gray-Matter and Whole-Brain Atrophy: a 15-Year Disease History Model Based on a 4-Year Longitudinal Study
    Horakova, D.
    Kyr, M.
    Havrdova, E.
    Dolezal, O.
    Lelkova, P.
    Pospisilova, L.
    Bergsland, N.
    Dwyer, M. G.
    Cox, J. L.
    Hussein, S.
    Seidl, Z.
    Vaneckova, M.
    Krasensky, J.
    Zivadinov, R.
    FOLIA BIOLOGICA, 2010, 56 (06) : 242 - 251
  • [2] A 4-year longitudinal study of gray matter atrophy in multiple sclerosis patients
    Fisher, Elizabeth
    Lee, Jar-Chi
    Nakamura, Kunio
    Rudick, Richard
    NEUROLOGY, 2008, 70 (11) : A242 - A243
  • [3] A Five-Year Serial Longitudinal Study of Deep Gray Matter Atrophy in Patients with Multiple Sclerosis
    Bergsland, Niels
    Horakova, Dana
    Dwyer, Michael G.
    Ramasamy, Deepa
    Havrdova, Eva
    Seidl, Zdenek
    Dolezal, Ondrej
    Hussein, Sara
    Carl, Ellen
    Vaneckova, Manuela
    Zivadinov, Robert
    NEUROLOGY, 2010, 74 (09) : A235 - A235
  • [4] Enzymotherapy in late onset Pompe disease patients: a 4-year longitudinal study using quantitative MRI
    Doche, E.
    Salort-Campana, E.
    Le Troter, A.
    Attarian, S.
    Pouget, J.
    Bendahan, D.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 868 - 869
  • [5] Intrathecal inflammatory profile predicts disease course in multiple sclerosis: a 4-year longitudinal study
    Calabrese, M.
    Pisani, A.
    Ziccardi, S.
    Pizzini, F. B.
    Bajrami, A.
    Tamanti, A.
    Guandalini, M.
    Bonomi, S.
    Rossi, S.
    Mazziotti, V.
    Montemezzi, S.
    Zuco, C.
    Crescenzo, F.
    Marastoni, D.
    Pitteri, M.
    Scalfari, A.
    Romualdi, C.
    Reynolds, R.
    Magliozzi, R.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 274 - 274
  • [6] Gray matter magnetic resonance imaging T2 hypointensity predicts whole-brain atrophy in multiple sclerosis: A 2-year longitudinal study
    Bakshi, R
    Puli, SR
    Tjoa, CW
    Bermel, RA
    Fisher, E
    Rudick, RA
    Fabiano, AJ
    Weinstock-Guttman, B
    Munschauer, FE
    Simon, JH
    ANNALS OF NEUROLOGY, 2002, 52 (03) : S76 - S76
  • [7] Progressive gray matter changes in first episode schizophrenia: A 4-year longitudinal magnetic resonance study using VBM
    Mane, Anna
    Falcon, Carles
    Javier Mateos, J.
    Fernandez-Egea, Emilio
    Horga, Guillermo
    Lomena, Francisco
    Bargallo, Nuria
    Prats-Galino, Alberto
    Bernardo, Miguel
    Parellada, Eduard
    SCHIZOPHRENIA RESEARCH, 2009, 114 (1-3) : 136 - 143
  • [8] Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis A 5-year longitudinal study
    Horakova, Dana
    Dwyer, Michael G.
    Havrdova, Eva
    Cox, Jennifer L.
    Dolezal, Ondrej
    Bergsland, Niels
    Rimes, Brett
    Seidl, Zdenek
    Vaneckova, Manuela
    Zivadinov, Robert
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 282 (1-2) : 112 - 119
  • [9] Disability and gray matter atrophy in multiple sclerosis patients with no evidence of disease activity: a one-year follow-up study
    Nygaard, G.
    Celius, E. G.
    Benavent, S. A. D. R.
    Sowa, P.
    Gustavsen, M. W.
    Fjell, A. M.
    Landro, N. I.
    Walhovd, K. B.
    Harbo, H. F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 253 - 253
  • [10] Effects of Natalizumab (Tysabri®) on Gray Matter Pathology in Patients with Relapsing Multiple Sclerosis: A 2-Year Follow-Up Brain Atrophy Study
    Zivadinov, Robert
    Dwyer, Michael
    Hussein, Sara
    Carl, Ellen
    Kennedy, Cheryl
    Andrews, Michelle
    Hojnacki, David
    Heininen-Brown, Mari
    Willis, Laura
    Cherneva, Mariya
    Bergsland, Niels
    Weinstock-Guttman, Bianca
    NEUROLOGY, 2011, 76 (09) : A323 - A324